SPRWF - The Supreme Cannabis Company, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

The Supreme Cannabis Company, Inc.

178R Ossington Avenue
Toronto, ON M6J 2Z7
Canada
416-630-7272
http://www.supreme.ca

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees750

Key Executives

NameTitlePayExercisedYear Born
Mr. Navdeep DhaliwalCEO & DirectorN/AN/AN/A
Mr. John Alexander FowlerFounder, Chief Advocacy Officer, MD of Flower & Concentrates and DirectorN/AN/AN/A
Ms. Sunpreet Kaur GokhaleGen. CounselN/AN/AN/A
Mr. Scott Robertson WaltersVP of Corp. Devel.N/AN/AN/A
Mr. Ramana DavloorGen. Mang. of 7ACRESN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

The Supreme Cannabis Company, Inc. engages in the production of medical cannabis in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.

Corporate Governance

The Supreme Cannabis Company, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.